C12Y 301/13001
Exoribonuclease ii
Official title: Exoribonuclease II (3.1.13.1)
C12Y301/13001 (Exoribonuclease ii) appears on 1 US grants and 7 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 7
- Assignees
- 6
- Inventors
- 27
- Latest grant
- 23 Mar 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 3 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods of making rna by splinted ligation and compositions thereof16 Jul 2026US 2026/0201394 A1Orbital Therapeutics, Inc.
- Methods of enriching for circular polyribonucleotides18 Jul 2024US 2024/0240218 A1Flagship Pioneering Innovations VI, LLC
- Antiviral compositions and methods15 Jun 2023US 2023/0181685 A1Wayne State University
- Cell-free production of ribonucleic acid26 May 2022US 2022/0162659 A1GreenLight Biosciences, Inc.
- Cell-free production of ribonucleic acid3 Mar 2022US 2022/0064688 A1GreenLight Biosciences, Inc.
Most cited
By later US patents